Latest Insider Transactions at Ligand Pharmaceuticals Inc (LGND)
This section provides a real-time view of insider transactions for Ligand Pharmaceuticals Inc (LGND). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LIGAND PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LIGAND PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2024
|
Todd C Davis Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,381
-1.89%
|
$102,194
$74.65 P/Share
|
|
Feb 15
2024
|
Octavio Espinoza Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,479
-6.46%
|
$109,446
$74.65 P/Share
|
|
Feb 15
2024
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,778
-5.07%
|
$353,572
$74.65 P/Share
|
|
Feb 15
2024
|
Andrew Reardon CLO & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
593
-3.8%
|
$43,882
$74.65 P/Share
|
|
Jan 02
2024
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,917
-3.0%
|
$210,024
$72.31 P/Share
|
|
Dec 29
2023
|
Andrew Reardon CLO & Secretary |
BUY
Other acquisition or disposition
|
Direct |
179
+1.14%
|
$10,740
$60.71 P/Share
|
|
Dec 05
2023
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,984
-2.0%
|
$117,056
$59.61 P/Share
|
|
Dec 05
2023
|
Octavio Espinoza Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,269
-5.25%
|
$74,871
$59.61 P/Share
|
|
Oct 01
2023
|
Octavio Espinoza Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-1.41%
|
$20,414
$59.92 P/Share
|
|
Sep 22
2023
|
Martine Zimmermann Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,285
+50.0%
|
-
|
|
Sep 22
2023
|
Todd C Davis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+5.19%
|
$236,000
$59.38 P/Share
|
|
Aug 10
2023
|
Andrew Reardon CLO & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
897
-5.5%
|
$60,996
$68.73 P/Share
|
|
Jun 30
2023
|
Octavio Espinoza Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
375
+1.51%
|
$21,000
$56.78 P/Share
|
|
Jun 30
2023
|
Matthew E Korenberg President & COO |
BUY
Other acquisition or disposition
|
Direct |
376
+0.38%
|
$21,056
$56.78 P/Share
|
|
Jun 09
2023
|
Stephen L Sabba Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,142
+4.07%
|
-
|
|
Jun 09
2023
|
John W Kozarich Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,142
+2.8%
|
-
|
|
Jun 09
2023
|
John L Lamattina Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,142
+3.88%
|
-
|
|
Jun 09
2023
|
Nancy Ryan Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,142
+14.81%
|
-
|
|
Jun 09
2023
|
Todd C Davis Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
420
-0.6%
|
$30,660
$73.76 P/Share
|
|
Jun 09
2023
|
Jason Haas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,142
+21.6%
|
-
|
|
Jun 09
2023
|
Jason Aryeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,142
+1.57%
|
-
|
|
May 16
2023
|
John W Kozarich Director |
SELL
Open market or private sale
|
Direct |
4,444
-10.35%
|
$342,188
$77.2 P/Share
|
|
May 10
2023
|
Stephen L Sabba Director |
SELL
Open market or private sale
|
Direct |
6,408
-19.91%
|
$493,416
$77.13 P/Share
|
|
May 10
2023
|
Stephen L Sabba Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+16.6%
|
-
|
|
May 08
2023
|
John W Kozarich Director |
SELL
Open market or private sale
|
Direct |
6,408
-6.67%
|
$487,008
$76.81 P/Share
|
|
May 08
2023
|
John W Kozarich Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+11.64%
|
$115,344
$18.82 P/Share
|
|
Mar 24
2023
|
Andrew Reardon CLO & Secretary |
SELL
Open market or private sale
|
Direct |
300
-1.81%
|
$20,700
$69.92 P/Share
|
|
Feb 23
2023
|
Todd C Davis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,005
+19.82%
|
-
|
|
Feb 23
2023
|
Andrew Reardon CLO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,668
+25.44%
|
-
|
|
Feb 23
2023
|
Matthew E Korenberg President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
9,069
+8.41%
|
-
|
|
Feb 23
2023
|
Octavio Espinoza Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,046
+20.03%
|
-
|
|
Feb 15
2023
|
Octavio Espinoza Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
849
-4.48%
|
$61,128
$72.98 P/Share
|
|
Feb 15
2023
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,890
-3.12%
|
$208,080
$72.98 P/Share
|
|
Dec 30
2022
|
Octavio Espinoza Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
275
+1.43%
|
$15,400
$56.78 P/Share
|
|
Dec 28
2022
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,289
-1.25%
|
$349,074
$66.29 P/Share
|
|
Dec 28
2022
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,859
-4.0%
|
$254,694
$66.29 P/Share
|
|
Dec 16
2022
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
10,000
-2.31%
|
$610,000
$61.87 P/Share
|
|
Dec 13
2022
|
Matthew E Korenberg President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+12.68%
|
-
|
|
Dec 13
2022
|
Octavio Espinoza Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+37.07%
|
-
|
|
Dec 12
2022
|
John L Higgins Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,944
-0.9%
|
$252,416
$64.8 P/Share
|
|
Dec 12
2022
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+4.38%
|
$240,000
$12.78 P/Share
|
|
Nov 30
2022
|
Andrew Reardon CLO & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,073
-8.93%
|
$77,256
$72.9 P/Share
|
|
Nov 30
2022
|
Octavio Espinoza Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,187
-13.4%
|
$85,464
$72.9 P/Share
|
|
Nov 30
2022
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,803
-2.3%
|
$705,816
$72.9 P/Share
|
|
Nov 30
2022
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,593
-4.18%
|
$258,696
$72.9 P/Share
|
|
Nov 18
2022
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.29%
|
$120,000
$12.78 P/Share
|
|
Nov 17
2022
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
10,000
-2.34%
|
$780,000
$78.32 P/Share
|
|
Nov 09
2022
|
Octavio Espinoza Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,696
-16.07%
|
$127,200
$75.64 P/Share
|
|
Nov 01
2022
|
John L Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,922
+9.76%
|
-
|
|
Nov 01
2022
|
Sarah Boyce |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,004
-25.77%
|
-
|